Changes in hepatic fibrosis after interferon-based therapy may be important in determining the long-term outcome of chronic hepatitis C (CHC). The use of liver biopsy for posttreatment assessment is not a viable option as a routine follow-up procedure. This study evaluated the predictive value of a
APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers
โ Scribed by Tung-Hung Su; Jia-Horng Kao; Ding-Shinn Chen
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 59 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
We recognize the confusing terminology but can confirm that the gene we cloned and sequenced from the mouse genomic library and therefore subsequently knocked out is definitely RegIIIbeta, which we also name as Reg-2 because it is the homolog of rat Reg-2.
To clarify the terminology, Table compares the nomenclature and clarifies the homologies of the various members of the Reg family. We believe that the confusion is due to the mixed usage of Arabic numerals (2 and 3) and Roman numerals (I, II, and III) adopted in previous papers. The table by Liu and Cui uses Arabic numerals, but in original articles, the usages are a mixture of Arabic and Roman. In any event, we agree the terminology is inconvenient (see Namikawa et al. 2 and Namikawa et al. 3 ).
๐ SIMILAR VOLUMES